Effects of metformin on disease flares in patients with systemic lupus erythematosus: post hoc analyses from two randomised trials.
Fangfang SunShikai GengHaiting WangHuijing WangZhe LiuXiaodong WangTing LiWeiguo WanLiangjing LuXiangyu TengLaurence MorelShuang YePublished in: Lupus science & medicine (2021)
Post hoc pooled analyses suggested that metformin reduced subsequent disease flares in patients with SLE with low disease activity, especially for serologically quiescent patients.
Keyphrases
- disease activity
- systemic lupus erythematosus
- rheumatoid arthritis
- end stage renal disease
- rheumatoid arthritis patients
- ankylosing spondylitis
- ejection fraction
- newly diagnosed
- chronic kidney disease
- juvenile idiopathic arthritis
- open label
- prognostic factors
- study protocol
- patient reported outcomes
- patient reported